MTOR and pancreatic neoplasm: Recent evidence has shown CXCR4-dependent mTOR signaling in pancreatic cancer, gastric cancer, and T-cell leukemia cells [25]; in fact, CXCR4 and mTOR inhibitors have been reported to impair human renal cancer migration [37].